ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,154, issued on Nov. 18, was assigned to OREXO AB (Uppsala, Sweden).
"Pharmaceutical composition comprising adrenaline" was invented by Jonas Savmarker (Uppsala, Sweden) and Robert Ronn (Uppsala, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a pharmaceutically-acceptable composition in the form of a solid, amorphous, mono-particulate powder comprising a mixture of: a pharmacologically-effective dosage amount of an adrenergic receptor modulator, or a pharmaceutically-acceptable salt thereof; and a pharmaceutically-acceptable carrier material, which carrier material comprises a maltodextrin with a dextrose equivalent (DE) that is a...